Appointment Companion Tool
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 21-004204
Sponsor Protocol Number: 21-004204
About this study
The purpose of this study is to pilot the patient appointment companion (PAC) tool in use with patients with amyloidosis and multiple myeloma (MM). Patients with hematologic malignancies have unique information and communication needs compared to those with solid tumors. The internet has shifted the dynamics of the patient–doctor relationship, toward one of more mutual participation whereby power and responsibility are shared. The PAC was designed as a patient-centered, user-friendly platform that aids patients’ preparation for their visits with clinicians. PAC provides an online tool that empowers patients to direct their treatment preferences and care alongside their physician teams per the provisions of HIPAA. Data will be collected to:
- Assess the feasibility of using PAC to prepare for clinic vists; and
- Assess the helpfulness/acceptability of the tool.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Diagnosis of multiple myeloma (MM) and/or amyloidosis (Systemic AL or ATTR).
- Age ≥ 18 years old.
- Planned monitoring and/or treatments as per standard of care for the incident disease.
- Anticipated return to clinic within 1-4 weeks of study enrollment, for a clinic visit that includes pre-visit PAC.
Exclusion Criteria:
- Age < 18 years old.
- Diapated return to clinic within 1-4 weeks of study enrollment, for a clinic visit that includes pre-visit PAC.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Morie Gertz, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available